Nintedanib and Nitroglycerin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nintedanib (nintedanib) and Nitroglycerin (nitroglycerin). Common drug interactions include coronary artery disease among females and acute coronary syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Nintedanib and Nitroglycerin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Nintedanib?

Nintedanib has active ingredients of nintedanib. eHealthMe is studying from 1,514 Nintedanib users. Check the latest studies of Nintedanib.

What is Nitroglycerin?

Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.

On Jul, 07, 2026

13 people who take Nintedanib and Nitroglycerin together, and have interactions are studied.

Nintedanib and Nitroglycerin drug interactions.

What are the common drug interactions of Nintedanib and Nitroglycerin, by gender? *:

female:

Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Respiratory failure (inadequate gas exchange by the respiratory system)
Idiopathic pulmonary fibrosis (chronic lung disease)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Acute myocardial infarction (acute heart attack)

male:

Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Diarrhoea
Disease progression
Rhinovirus infection
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Idiopathic pulmonary fibrosis (chronic lung disease)
Pulmonary embolism (blockage of the main artery of the lung)
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Nintedanib and Nitroglycerin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)

60+:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Pulmonary embolism (blockage of the main artery of the lung)
Diarrhoea
Respiratory failure (inadequate gas exchange by the respiratory system)
Acute myocardial infarction (acute heart attack)
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Disease progression
Idiopathic pulmonary fibrosis (chronic lung disease)
Rhinovirus infection

What are the existing conditions these people have? *

Idiopathic Pulmonary Fibrosis (chronic lung disease): 8 people, 61.54%
High Blood Pressure: 7 people, 53.85%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 4 people, 30.77%
Interstitial Lung Disease: 3 people, 23.08%
High Blood Cholesterol: 2 people, 15.38%
Gastritis (inflammation of stomach): 2 people, 15.38%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 15.38%
Sleep Disorder: 2 people, 15.38%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 7.69%
Stable Angina (a constant chest pain): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Nintedanib and Nitroglycerin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously